According to the WSJ, the FBI is looking into what J&J knew about the risks posed by the device, which is used to perform hysterectomies. However, a J&J spokesman told the newspaper that he wasn’t aware of an investigation into the device.
The bureau has interviewed a retired pathologist who warned the manufacturer that the morcellators could pose a risk, as well as a physician personally affected by the device and a woman who has collected names of patients and families also affected by it, according to the WSJ.
Several hospitals, like Massachusetts General and Brigham and Women’s in Boston, have limited their use of the devices in recent years.
More articles on patient safety:
Study examines link between CLABSIs and readmissions: 3 findings
As temperatures rise in the summer, so do common SSIs
12 California hospitals penalized for patient safety issues
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.